MMP7 and cholangiocarcinoma: DKK1 has been shown to regulate tumorigenicity and invasion in CCA through the β-catenin/matrix metalloproteinase-7 (MMP-7) pathway [87], in addition to promoting tumor immune evasion through the recruitment of immune suppressive macrophages, [88] and has therefore been proposed as a potential therapeutic target.